The Quarter 1, 2022 billing codes for drugs and biologics and MedTech have been posted. However,[…]
Read more
What Should You Do Now that You Have Your 2022 #Drug and MedTech Codes?
The Quarter 1, 2022 billing codes for drugs and biologics and MedTech have been posted. […]
Read more
Is FDA Approval Enough for Market Adoption?
This week, the Food and Drug Administration (FDA) approved two drugs that made the headlines[…]
Read more
Do You Need to Comment on the CMS Proposed Rule for Inpatient Prospective Payment Systems and Long Term Care for Hospital Patients?
On April 27, 2021, the Centers for Medicare & Medicaid Services (CMS) published a new[…]
Read more
GIRS Successfully Assists with the Overturning of Claims Denials
A provider contacted the GIRS InContact Reimbursement Hotline® team for assistance with a denial of[…]
Read more
Track Japan’s Drug Price Changes-for Market Access!
For more information, email us at info@girsinc.com or call us at 901-834-9119. Japan is instituting[…]
Read moreLatest Posts
What Should You Do Now that You Have Your 2022 #Drug and MedTech Codes?
The Quarter 1, 2022 billing codes for drugs and biologics and MedTech have been posted. However, being assigned a code does[…]
Read more
What Should You Do Now that You Have Your 2022 #Drug and MedTech Codes?
The Quarter 1, 2022 billing codes for drugs and biologics and MedTech have been posted. However, being assigned a code[…]
Read more
Is FDA Approval Enough for Market Adoption?
This week, the Food and Drug Administration (FDA) approved two drugs that made the headlines because they were drugs that[…]
Read more
The U.S is Gearing up to Boost Drug Production – Five Key Considerations if You are Developing a New Drug.
To prevent the shortages that were a result of the COVID-19 pandemic, on February 24, 2021, President Biden signed Executive[…]
Read more
ICD-10-PCS codes and guidelines for the 2022 fiscal year
The Centers for Medicare & Medicaid Services (CMS) published the final ICD-10-PCS codes and guidelines for the 2022 fiscal year[…]
Read more
As Two Proposed Bills are Considered for Telehealth, How Could it Impact your Products?
In the past year, the pandemic has changed the nature of how we operate in our day-to-day lives. Among them,[…]
Read more
As CMS Updates its Hospital Outpatient Prior Authorization List for 2021, are Your Accounts Educated About the 2021 Changes?
In June 2020, the Centers for Medicare and Medicaid Services (CMS) implemented a prior authorization (PA) program for certain hospital outpatient[…]
Read more
Federally Funded Health Centers Gain $1 Billion in Funding, Are You Aware of Their Importance in Improving Access to Your Products and Improving Patient Compliance?
Following the latest in reimbursement news, we recently covered the $80 million in funding for Navigators in Federal Marketplaces for[…]
Read more
Do You Need to Comment on the CMS Proposed Rule for Inpatient Prospective Payment Systems and Long Term Care for Hospital Patients?
On April 27, 2021, the Centers for Medicare & Medicaid Services (CMS) published a new proposed rule for Fiscal Year[…]
Read more
Are You Strategizing for Market Access Given Centene’s Medicaid Expansion Trends?
Centene Corporation (Centene) is an important payer for our clients, and we have tracked the trends with this payer to[…]
Read more